One-Year Outcomes of Percutaneous Coronary Intervention in Patients with End-Stage Liver Disease.

Lu, Daniel Y; Saybolt, Matthew D; Kiss, Daniel H; Matthai, William H; Forde, Kimberly A; Giri, Jay; Wilensky, Robert L

Lu, Daniel Y; Saybolt, Matthew D; Kiss, Daniel H; Matthai, William H; Forde, Kimberly A; Giri, Jay; Wilensky, Robert L.

Afiliación

Lu DY; New York Presbyterian Hospital - Weill Cornell Medical Center, New York, NY, USA.
Saybolt MD; Hackensack Meridian Health Jersey Shore University Medical Center, Neptune, NJ, USA.
Kiss DH; Hackensack Meridian Health Jersey Shore University Medical Center, Neptune, NJ, USA.
Matthai WH; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Forde KA; Division of Cardiovascular Medicine, Penn Presbyterian Medical Center, Philadelphia, PA, USA.
Giri J; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Wilensky RL; Division of Gastroenterology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.

Clin Med Insights Cardiol ; 14: 1179546820901491, 2020.

Article en En | MEDLINE | ID: mdl-32030068

Palabras clave

PCI; cirrhosis; dual antiplatelet therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Med Insights Cardiol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google